Literature DB >> 26883219

Modeling correlates of low bone mineral density in patients with phenylalanine hydroxylase deficiency.

Kathryn E Coakley1,2, Teresa D Douglas3, Michael Goodman4,5, Usha Ramakrishnan4,6, Steven F Dobrowolski7, Rani H Singh4,8.   

Abstract

Phenylalanine hydroxylase (PAH) deficiency is an inherited metabolic disorder requiring life-long restriction of dietary protein and phenylalanine-free medical food. Low bone mineral density (BMD) is reported, but factors associated with BMD Z-score (standard deviations from normal) are unknown. We examined associations between clinical and dietary parameters and total BMD Z-score in PAH deficiency patients, and developed models to predict Z-score. Data collected from patients >4 years of age (n = 88; mean age = 18.8 y; 61 % female) included demographic, clinical, laboratory, and dietary intakes. Adjusted Spearman's correlation coefficients were calculated between parameters and TBMD Z-score, measured by dual energy x-ray absorptiometry (DXA). Parameters approaching significance (p-value < 0.10) were candidate predictors for four linear regression models predicting TBMD Z-score. To validate, model-predicted Z-scores were compared to DXA Z-scores. Mean TBMD Z-score was -0.326; 18 (20.4 %) had Z-score < -1. Z-scores were positively correlated with dietary vitamin D, calcium, and medical food intake and compliance with prescription, and negatively with dietary carbohydrate, sugar, caffeine intake, glycemic load, and prescribed medical food (grams protein/day; p-value < 0.05). The best model included medical food compliance, medical food intake, caffeine intake, and bone-specific alkaline phosphatase (r-square = 0.364). This model predicted Z-score category [normal or low (<-1)] with sensitivity = 66.7 %, likelihood ratio = 14.7, and AUC = 0.83 compared to DXA Z-score. No subjects had low BMD for chronological age (Z-score ≤ -2). Compliance with medical food prescription was the strongest predictor of TBMD Z-score. One model, if validated in a separate sample of patients with more cases of low BMD, showed potential to estimate TBMD Z-score using routine clinical patient parameters.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26883219     DOI: 10.1007/s10545-015-9910-0

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  39 in total

Review 1.  FRAX and its applications to clinical practice.

Authors:  John A Kanis; Anders Oden; Helena Johansson; Fredrik Borgström; Oskar Ström; Eugene McCloskey
Journal:  Bone       Date:  2009-02-03       Impact factor: 4.398

2.  Dual energy X-ray absorptiometry.

Authors:  Tania Winzenberg; Graeme Jones
Journal:  Aust Fam Physician       Date:  2011 Jan-Feb

3.  Caffeine and other predictors of bone density among pre- and perimenopausal women.

Authors:  M Hernández-Avila; M J Stampfer; V A Ravnikar; W C Willett; I Schiff; M Francis; C Longcope; S M McKinlay; C ] Longscope C [corrected to Longcope
Journal:  Epidemiology       Date:  1993-03       Impact factor: 4.822

4.  Effect of supplementation of calcium and vitamin D on bone mineral density and bone mineral content in peri- and post-menopause women; a double-blind, randomized, controlled trial.

Authors:  Nicola Di Daniele; Maria Grazia Carbonelli; Nicola Candeloro; Leonardo Iacopino; Antonino De Lorenzo; Angela Andreoli
Journal:  Pharmacol Res       Date:  2004-12       Impact factor: 7.658

Review 5.  Pediatric bone densitometry.

Authors:  Cornelis van Kuijk
Journal:  Radiol Clin North Am       Date:  2010-05       Impact factor: 2.303

6.  Body mass index as a measure of adiposity among children and adolescents: a validation study.

Authors:  A Pietrobelli; M S Faith; D B Allison; D Gallagher; G Chiumello; S B Heymsfield
Journal:  J Pediatr       Date:  1998-02       Impact factor: 4.406

7.  New era in treatment for phenylketonuria: Pharmacologic therapy with sapropterin dihydrochloride.

Authors:  Cary O Harding
Journal:  Biologics       Date:  2010-08-09

8.  Carbohydrate metabolism in phenylketonuria.

Authors:  R M Stewart; S Hemli; E H Kolodny; A L Miller; J A Pallotta
Journal:  Pediatr Res       Date:  1980-07       Impact factor: 3.756

9.  A computer-based approach for assessing dietary supplement use in conjunction with dietary recalls.

Authors:  Lisa Harnack; Mary Stevens; Nancy Van Heel; Sally Schakel; Johanna T Dwyer; John Himes
Journal:  J Food Compost Anal       Date:  2008-02       Impact factor: 4.556

Review 10.  Recommendations for the nutrition management of phenylalanine hydroxylase deficiency.

Authors:  Rani H Singh; Fran Rohr; Dianne Frazier; Amy Cunningham; Shideh Mofidi; Beth Ogata; Patricia L Splett; Kathryn Moseley; Kathleen Huntington; Phyllis B Acosta; Jerry Vockley; Sandra C Van Calcar
Journal:  Genet Med       Date:  2014-01-02       Impact factor: 8.822

View more
  7 in total

1.  Amino Acid Medical Foods Provide a High Dietary Acid Load and Increase Urinary Excretion of Renal Net Acid, Calcium, and Magnesium Compared with Glycomacropeptide Medical Foods in Phenylketonuria.

Authors:  Bridget M Stroup; Emily A Sawin; Sangita G Murali; Neil Binkley; Karen E Hansen; Denise M Ney
Journal:  J Nutr Metab       Date:  2017-05-04

2.  Large neutral amino acid status in association with P:T ratio and diet in adult and pediatric patients with phenylketonuria.

Authors:  Teresa D Douglas; Anita M Nucci; Ann M Berry; Sarah T Henes; Rani H Singh
Journal:  JIMD Rep       Date:  2019-09-16

3.  Glutamine energy substrate anaplerosis increases bone density in the Pahenu2 classical PKU mouse in the absence of phenylalanine restriction.

Authors:  Steven F Dobrowolski; Yu Leng Phua; Irina L Tourkova; Cayla Sudano; Jerry Vockley; Quitterie C Larrouture; Harry C Blair
Journal:  JIMD Rep       Date:  2022-07-06

4.  Sex differences in body composition and bone mineral density in phenylketonuria: A cross-sectional study.

Authors:  Bridget M Stroup; Karen E Hansen; Diane Krueger; Neil Binkley; Denise M Ney
Journal:  Mol Genet Metab Rep       Date:  2018-02-03

5.  Bone mineral density is within normal range in most adult phenylketonuria patients.

Authors:  Charlotte M A Lubout; Francisco Arrieta Blanco; Katarzyna Bartosiewicz; François Feillet; Maria Gizewska; Carla Hollak; Johanna H van der Lee; François Maillot; Karolina M Stepien; Margreet A E M Wagenmakers; Mendy M Welsink-Karssies; Francjan J van Spronsen; Annet M Bosch
Journal:  J Inherit Metab Dis       Date:  2020-02-06       Impact factor: 4.982

6.  Sex effects of dietary protein source and acid load on renal and bone status in the Pahenu2 mouse model of phenylketonuria.

Authors:  Bridget M Stroup; Sangita G Murali; Denise J Schwahn; Emily A Sawin; Emma M Lankey; Hans Peter Bächinger; Denise M Ney
Journal:  Physiol Rep       Date:  2019-10

7.  Bone Status in Patients with Phenylketonuria: A Systematic Review.

Authors:  María José de Castro; Carmela de Lamas; Paula Sánchez-Pintos; Domingo González-Lamuño; María Luz Couce
Journal:  Nutrients       Date:  2020-07-20       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.